Haemonetics Corp
NYSE:HAE

  • LAST PRICE
    95.7300
  • TODAY'S CHANGE (%)
    0.0000 (0.0000%)
  • Bid / Lots
    92.6700/ 1
  • Ask / Lots
    98.7800/ 1
  • Open / Previous Close
    94.8200 / 95.7300
  • Day Range
    94.0200
    95.8200
  • 52 Week Range
    70.7400
    97.9700
  • Volume
    212,897

Search Criteria

Click on magnifying glass icon to search

CompanyCountrySymbol

Charts

Price Comparison Graph. See accessible table below
Data delayed at least 15 minutes.

Medical Equipment, Supplies & Distribution Industry Peers

CompanyMarket CapP/E Ratio (TTM)EPS Growth (5yr)
HAE
Haemonetics Corp
4.9B
38.7x
+10.35%
MMSI
Merit Medical Systems Inc
4.8B
47.0x
+14.05%
LNTH
Lantheus Holdings Inc
5.5B
12.2x
+35.30%
INSP
Inspire Medical Systems Inc
4.6B
-288.8x
---
LIVN
LivaNova PLC
3.4B
-104.8x
---
GKOS
Glaukos Corp
5.5B
-38.1x
---
As of 2024-05-20

Company Information

Haemonetics Corporation is a global healthcare company. The Company provides a suite of medical products and solutions for customers to help them improve patient care and reduce the cost of healthcare. Its technology addresses three medical markets: blood and plasma component collection, the surgical suite, and hospital transfusion services. Its segments include Plasma, Blood Center, and Hospital. Its Plasma segment offers automated plasma collection systems, donor management software, and supporting software solutions that improve the donor experience at plasma collection centers. Its Blood Center segment offers a range of solutions that improve donor collection centers' ability to collect and separate blood components for transfusions. Its Hospital segment provides patient care and has four product lines: hemostasis management, vascular closure, cell salvage, and transfusion management. Its portfolio also includes fiber optic sensor technology in the interventional cardiology market.

Contact Information

Headquarters
125 Summer StreetBOSTON, MA, United States 02110
Phone
781-848-7100
Fax
---

Executives

Independent Chairman of the Board
Ellen Zane
President, Chief Executive Officer
Christopher Simon
Executive Vice President, Chief Financial Officer
James D'arecca
President - Global Plasma and Blood Center
Roy Galvin
President - Global Hospital
Stewart Strong

Ratings

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

Reports

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals

Market Cap
$4.9B
Revenue (TTM)
$1.3B
Shares Outstanding
50.8M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
0.40
EPS
$2.47
Book Value
$16.21
P/E Ratio
38.7x
Price/Sales (TTM)
3.8
Price/Cash Flow (TTM)
22.1x
Operating Margin
13.40%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Calendar

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.